
Moroccan pharma executive Lamia Tazi gains $8.14 million from Sothema stake
Tazi holds an 8.19 percent stake in Sothema, equivalent to 589,658 shares.
Tazi holds an 8.19 percent stake in Sothema, equivalent to 589,658 shares.
Lamia Tazi’s stake in Sothema dips below $65 million as shares slide
The recent financial setback experienced by Tazi underscores the broader challenges facing Sothema and highlights the unpredictable nature of the stock market.
Tazi, the CEO and chairperson of Sothema holds a substantial 8.4-percent stake in the leading healthcare company.
Tazi holds a substantial 8.4-percent stake in the leading healthcare company, or 605,030 issued shares.